We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+10.3%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$4.63B
AUM Growth
+$366M
Cap. Flow
-$26.7M
Cap. Flow %
-0.58%
Top 10 Hldgs %
31.03%
Holding
660
New
37
Increased
195
Reduced
232
Closed
27

Sector Composition

Rank Sector Weight
1 Technology 21.44%
2 Healthcare 15.85%
3 Financials 11.9%
4 Consumer Staples 8.99%
5 Communication Services 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QVCGA
451
DELISTED
QVC Group Inc Series A
QVCGA
$144K ﹤0.01%
378
VTRS icon
452
Viatris
VTRS
$20.4B
$141K ﹤0.01%
10,445
-1,325
-11% -$17.7K
SH icon
453
ProShares Short S&P500
SH
$907M
$136K ﹤0.01%
2,500
-10,625
-81% -$603K
PBPB
454
DELISTED
Potbelly
PBPB
$112K ﹤0.01%
20,000
DFTX
455
Definium Therapeutics
DFTX
$5.78B
$100K ﹤0.01%
4,833
ATAI icon
456
AtaiBeckley Inc
ATAI
$2.66B
$98K ﹤0.01%
+12,800
New +$155K
FUV
457
DELISTED
Arcimoto, Inc. Common Stock
FUV
$86K ﹤0.01%
550
PSIL icon
458
AdvisorShares Psychedelics ETF
PSIL
$48.9M
$69K ﹤0.01%
+1,200
New +$96K
LFMD icon
459
LifeMD
LFMD
$169M
$58K ﹤0.01%
15,000
+2,750
+22% +$13K
HELP
460
Cybin Inc
HELP
$485M
$48K ﹤0.01%
1,053
+395
+60% +$25K
LFLYW
461
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$45K ﹤0.01%
40,000
+15,000
+60% +$19.8K
IMCC
462
IM Cannabis
IMCC
$1.04M
$33K ﹤0.01%
167
NYMX
463
DELISTED
Nymox Pharmaceutical Corp
NYMX
$33K ﹤0.01%
25,000
UP.WS
464
DELISTED
Wheels Up Experience Inc. Redeemable Warrants, each warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 per whole share of Common Stock
UP.WS
$29K ﹤0.01%
+35,000
New +$42.3K
DNN icon
465
Denison Mines
DNN
$2.54B
$27K ﹤0.01%
20,000
REUN
466
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
$25K ﹤0.01%
2,000
GNLN icon
467
Greenlane Holdings
GNLN
$1.22M
0
NWBO
468
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$9K ﹤0.01%
12,740
EVFM
469
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$4K ﹤0.01%
667
ABM icon
470
ABM Industries
ABM
$2.81B
-4,800
Closed -$216K
AUPH icon
471
Aurinia Pharmaceuticals
AUPH
$1.91B
-9,500
Closed -$210K
BCTX
472
Briacell Therapeutics
BCTX
$29.9M
-67
Closed -$81K
DXJ icon
473
WisdomTree Japan Hedged Equity Fund
DXJ
$7.08B
-4,100
Closed -$259K
IP icon
474
International Paper
IP
$21.6B
-4,440
Closed -$235K
MRNA icon
475
Moderna
MRNA
$21.8B
-576
Closed -$222K

Similar funds

Gofen & Glossberg's Q4 2021 Portfolio in Review

As of Q4 2021, Gofen & Glossberg held 660 positions worth $4.63B, up 8.6% from $4.27B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Gofen & Glossberg's Q4 2021 filing shows 37 new, 195 increased, 232 reduced and 27 closed positions. Its largest new stake was T-Mobile US: 11,274 shares worth $1.31M. The largest sale was Kansas City Southern, an estimated $30.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Gofen & Glossberg's largest Q4 2021 buy was T-Mobile US: 11,274 shares worth $1.31M.
  • Gofen & Glossberg added most to Canadian Pacific Kansas City in Q4 2021, an estimated $23M increase.
  • Gofen & Glossberg's biggest Q4 2021 reduction was Apple, cutting an estimated $12.8M.
  • Gofen & Glossberg fully exited Kansas City Southern in Q4 2021, selling an estimated $30.8M.
  • Gofen & Glossberg's ten largest holdings make up 31% of its $4.63B portfolio in Q4 2021.
  • Gofen & Glossberg opened 37 new positions and closed 27 in Q4 2021.
  • Gofen & Glossberg's portfolio value rose 8.6% quarter-over-quarter to $4.63B.

Based on Gofen & Glossberg's 13F filing for Q4 2021, filed 25 Jan 2022.